Chon Lai
Impact in
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Melanoma and MAPK Pathways
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 4
- Genomics and Chromatin Dynamics 2
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- Melanoma and MAPK Pathways 2
- Oncology 3
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Lihong Shi (5 shared papers)Jean‐Michel Vernier (3 shared papers)Todd Vo (2 shared papers)Barry Quart (2 shared papers)Ryan Stansfield (4 shared papers)Cory Iverson (2 shared papers)Jeffrey N. Miner (1 shared paper)Gary Larson (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (2 papers)Journal of Medicinal Chemistry (1 paper)The American Journal of Gastroenterology (1 paper)Journal of Chemical Information and Modeling (1 paper)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Chon Lai
10 papers receiving 365 citations
Peers
Comparison fields: 5 of 51
- Molecular Biology 283
- Oncology 61
- Pathology and Forensic Medicine 32
- Cancer Research 26
- Organic Chemistry 55
Countries citing papers authored by Chon Lai
This map shows the geographic impact of Chon Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chon Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chon Lai more than expected).
Fields of papers citing papers by Chon Lai
This network shows the impact of papers produced by Chon Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chon Lai. The network helps show where Chon Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Chon Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 156 | |
| 2 | 2020 | 96 | |
| 3 | 2017 | 52 | |
| 4 | 2018 | 32 | |
| 5 | 2023 | 15 | |
| 6 | 2018 | 12 | |
| 7 | 2024 | 4 | |
| 8 | RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer | 2007 | 3 |
| 9 | 2008 | 2 | |
| 10 | 2025 | 1 |
About Chon Lai
Chon Lai is a scholar working on Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, Immunology and Allergy and Infectious Diseases, having authored 10 papers that have together received 373 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers), Genomics and Chromatin Dynamics (2 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Melanoma and MAPK Pathways (2 papers), Cell Adhesion Molecules Research (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Molecular Biology (283 citations), Oncology (61 citations), Pathology and Forensic Medicine (32 citations), Cancer Research (26 citations) and Organic Chemistry (55 citations). Chon Lai has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Lihong Shi, Jean‐Michel Vernier, Todd Vo, Barry Quart, Ryan Stansfield, Cory Iverson, Jeffrey N. Miner, Gary Larson, Jeffrey A. Stafford and T.C. Appleby. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, The American Journal of Gastroenterology and Journal of Chemical Information and Modeling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.